LUC00133I2 - - Google Patents
Download PDFInfo
- Publication number
- LUC00133I2 LUC00133I2 LU00133C LUC00133C LUC00133I2 LU C00133 I2 LUC00133 I2 LU C00133I2 LU 00133 C LU00133 C LU 00133C LU C00133 C LUC00133 C LU C00133C LU C00133 I2 LUC00133 I2 LU C00133I2
- Authority
- LU
- Luxembourg
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/51—Lyases (4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/807,227 US7534595B2 (en) | 2006-06-12 | 2007-05-25 | Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof |
| LU2008006661 | 2008-05-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LUC00133I1 LUC00133I1 (fr) | 2019-10-16 |
| LUC00133I2 true LUC00133I2 (fr) | 2020-07-16 |
Family
ID=39868905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU00133C LUC00133I2 (fr) | 2007-05-25 | 2019-10-14 |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US7534595B2 (fr) |
| EP (2) | EP2657335A1 (fr) |
| JP (1) | JP5670183B2 (fr) |
| KR (2) | KR20150038753A (fr) |
| CN (1) | CN101842482B (fr) |
| AR (2) | AR066716A1 (fr) |
| AU (1) | AU2008263190B2 (fr) |
| BR (1) | BRPI0811267B8 (fr) |
| CA (1) | CA2687450C (fr) |
| CL (1) | CL2008001497A1 (fr) |
| CY (2) | CY1116894T1 (fr) |
| DK (1) | DK2152868T3 (fr) |
| EA (1) | EA018443B1 (fr) |
| ES (1) | ES2551315T3 (fr) |
| HR (1) | HRP20151268T1 (fr) |
| HU (2) | HUE025784T2 (fr) |
| IL (1) | IL202132A (fr) |
| LT (1) | LTC2152868I2 (fr) |
| LU (1) | LUC00133I2 (fr) |
| MX (1) | MX2009012453A (fr) |
| MY (1) | MY151413A (fr) |
| NL (1) | NL301011I2 (fr) |
| NO (1) | NO2019037I1 (fr) |
| PE (1) | PE20090315A1 (fr) |
| PL (1) | PL2152868T3 (fr) |
| PT (1) | PT2152868E (fr) |
| SI (1) | SI2152868T1 (fr) |
| TW (1) | TWI418633B (fr) |
| WO (1) | WO2008153776A1 (fr) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7534595B2 (en) | 2006-06-12 | 2009-05-19 | Biomarin Pharmaceutical Inc. | Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof |
| US7531341B1 (en) | 2006-06-12 | 2009-05-12 | Biomarin Pharmaceutical Inc. | Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof |
| US7560263B2 (en) | 2007-08-17 | 2009-07-14 | Biomarin Pharmaceutical Inc. | Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof |
| WO2010014225A2 (fr) * | 2008-07-30 | 2010-02-04 | Biomarin Pharmaceutical Inc. | Dosages permettant la détection de la phénylalanine ammoniac-lyase et des anticorps contre la phénylalanine ammoniac-lyase |
| ES2690542T3 (es) | 2010-02-04 | 2018-11-21 | Biomarin Pharmaceutical Inc. | Método para purificar variantes de fenilalanina amoníaco-liasa procariotas |
| US20150246083A1 (en) * | 2012-07-27 | 2015-09-03 | University Of North Texas | Genetically modified probiotic for the treatment of phenylketonuria (pku) disease |
| SMT201900315T1 (it) | 2013-04-18 | 2019-07-11 | Codexis Inc | Polipeptidi di fenilalanina ammoniaca liasi ingegnerizzati |
| EP3071515A2 (fr) | 2013-11-18 | 2016-09-28 | Rubius Therapeutics, Inc. | Complexes membrane synthétique- récepteur |
| HUE054471T2 (hu) | 2014-04-01 | 2021-09-28 | Rubius Therapeutics Inc | Immunmodulációs módszerek és készítmények |
| EP3928787A1 (fr) | 2014-04-16 | 2021-12-29 | Codexis, Inc. | Tyrosine ammoniac-lyase génétiquement modifiée |
| FI3237621T3 (fi) | 2014-12-22 | 2023-06-01 | Codexis Inc | Ihmisen alfa-galaktosidaasivariantteja |
| TWI899515B (zh) * | 2015-08-04 | 2025-10-01 | 美商再生元醫藥公司 | 補充牛磺酸之細胞培養基及用法 |
| IL263801B2 (en) | 2016-07-26 | 2024-01-01 | Biomarin Pharm Inc | Novel adeno-associated virus capsid proteins |
| WO2018043546A1 (fr) * | 2016-08-30 | 2018-03-08 | 三菱ケミカル株式会社 | Procédé de production d'une enzyme mutante, et alcool acyltransférase mutante |
| CN106497905A (zh) * | 2016-12-14 | 2017-03-15 | 江南大学 | 一株鱼腥藻来源的苯丙氨酸脱氨酶的突变体 |
| CA3051262A1 (fr) | 2017-02-13 | 2018-08-16 | Codexis, Inc. | Polypeptides de phenylalanine ammonia-lyase modifies |
| CN107653275A (zh) * | 2017-10-30 | 2018-02-02 | 安徽工程大学 | D‑苯丙氨酸的制备方法 |
| CN108004225B (zh) * | 2017-12-19 | 2020-05-08 | 江南大学 | 一种成团泛菌来源的苯丙氨酸氨基变位酶的突变体 |
| JP2021522811A (ja) | 2018-05-09 | 2021-09-02 | ビオマリン プハルマセウトイカル インコーポレイテッド | フェニルケトン尿症の治療方法 |
| TW202005978A (zh) | 2018-05-14 | 2020-02-01 | 美商拜奧馬林製藥公司 | 新穎肝靶向腺相關病毒載體 |
| WO2019241132A1 (fr) * | 2018-06-12 | 2019-12-19 | Codexis, Inc. | Tyrosine ammonia-lyase modifiée |
| US11198861B2 (en) * | 2018-07-12 | 2021-12-14 | Codexis, Inc. | Engineered phenylalanine ammonia lyase polypeptides |
| AU2019397401A1 (en) | 2018-12-14 | 2021-06-17 | Codexis, Inc. | Engineered tyrosine ammonia lyase |
| EP3898960A4 (fr) | 2018-12-20 | 2022-11-30 | Codexis, Inc. | Variants d'alpha-galactosidase humaine |
| CN110456056A (zh) * | 2019-07-22 | 2019-11-15 | 浙江大学 | 一种新生儿苯丙酮尿症无创筛查试纸的制备方法 |
| MX2022002473A (es) | 2019-08-30 | 2022-08-02 | Codexis Inc | Variantes de lipasa modificadas geneticamente. |
| WO2021127457A1 (fr) | 2019-12-20 | 2021-06-24 | Codexis, Inc. | Variants d'alpha-glucosidase acide modifiés |
| CN116113691A (zh) | 2020-02-04 | 2023-05-12 | 科德克希思公司 | 工程化亮氨酸脱羧酶 |
| WO2021168060A1 (fr) * | 2020-02-19 | 2021-08-26 | Trustees Of Tufts College | Procédés d'ingénierie d'enzymes amino acide ammonia lyase et enzymes ainsi obtenues |
| AR122409A1 (es) | 2020-04-03 | 2022-09-07 | Biomarin Pharm Inc | Tratamiento de la fenilcetonuria con aav y formulaciones terapéuticas |
| AU2021331493A1 (en) | 2020-08-28 | 2023-03-09 | Codexis, Inc. | Engineered amylase variants |
| EP4204554A4 (fr) | 2020-08-28 | 2024-08-21 | Codexis, Inc. | Variants de protéase modifiés |
| WO2022245924A1 (fr) * | 2021-05-19 | 2022-11-24 | Biomarin Pharmaceutical Inc. | Compositions de phénylalanine ammonia-lyase procaryotique et méthodes de traitement de sujets adolescents |
| TW202313969A (zh) | 2021-05-21 | 2023-04-01 | 美商克迪科思股份有限公司 | 經工程化的甲硫胺酸γ解離酶變異體 |
| US20250000957A1 (en) * | 2021-09-16 | 2025-01-02 | Arcturus Therapeutics, Inc. | Compositions and methods for treating phenylketonuria |
| WO2023077169A2 (fr) | 2021-11-01 | 2023-05-04 | Codexis, Inc. | Leucine décarboxylases modifiées |
| CN117417925A (zh) * | 2022-07-18 | 2024-01-19 | 浙江泽科塔生物医药有限公司 | Pal变体、包含该pal变体的药物组合物以及用于制备该pal变体的方法 |
| CN118931888A (zh) * | 2023-05-09 | 2024-11-12 | 重庆派金生物科技有限公司 | 苯丙氨酸裂解酶突变体及其偶联物或其药学上可接受的盐 |
| GB202307239D0 (en) | 2023-05-15 | 2023-06-28 | Evox Therapeutics Ltd | Gene therapies for Phenylketonuria |
| CN116478975B (zh) * | 2023-06-16 | 2023-09-01 | 苏州优信合生技术有限公司 | 高活性苯丙氨酸解氨酶突变体及其表达菌株 |
| TW202521161A (zh) | 2023-11-17 | 2025-06-01 | 美商拜奧馬林製藥公司 | 苯丙胺酸解氨酶與poegma之結合物及其使用方法 |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4252822A (en) | 1979-12-26 | 1981-02-24 | Children's Hospital Medical Center | Method for treating phenylketonuria |
| US4562151A (en) | 1983-09-06 | 1985-12-31 | Monsanto Company | Stabilization of L-phenylalanine ammonia-lyase enzyme |
| US5206344A (en) | 1985-06-26 | 1993-04-27 | Cetus Oncology Corporation | Interleukin-2 muteins and polymer conjugation thereof |
| US5166322A (en) | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof |
| US5766897A (en) | 1990-06-21 | 1998-06-16 | Incyte Pharmaceuticals, Inc. | Cysteine-pegylated proteins |
| JP2930723B2 (ja) | 1992-11-19 | 1999-08-03 | アンティキャンサー インコーポレーテド | 抗メチオニン化学療法における抗腫瘍薬としてのメチオニナーゼの使用 |
| ATE361984T1 (de) | 1992-12-04 | 2007-06-15 | Me Medical Enzymes Ag | Gentechnologisch hergestellte glutaminase und ihre verwendung in therapie |
| DK75593D0 (fr) | 1993-06-25 | 1993-06-25 | Novo Nordisk As | |
| EP0776218A2 (fr) * | 1994-03-15 | 1997-06-04 | Prizm Pharmaceuticals, Inc. | Facteurs de croissance des fibroplastes pour la therapie genique et le traitement de troubles du segment anterieur de l'oeil |
| JP3628333B2 (ja) | 1995-09-21 | 2005-03-09 | ジェネンテック インコーポレーテッド | ヒト成長ホルモン変異体 |
| CU22585A1 (es) * | 1995-11-17 | 1999-11-03 | Centro Inmunologia Molecular | Anticuerpos monoclonales antiidiótipos (ab2) de tipo igg con alta conectividad idiotípica y composiciones farmacéuticas que los contienen. su uso como inmunoreguladores de la respuesta inmune. |
| US6548644B1 (en) | 1997-03-10 | 2003-04-15 | Immunex Corporation | Site protected protein modification |
| US6183738B1 (en) | 1997-05-12 | 2001-02-06 | Phoenix Pharamacologics, Inc. | Modified arginine deiminase |
| US5981239A (en) | 1997-09-24 | 1999-11-09 | Great Lakes Chemical Corp. | Synthesis of optically active phenylalanine analogs using Rhodotorula graminis |
| CA2315944A1 (fr) * | 1997-12-24 | 1999-07-08 | Diatech Pty. Ltd. | Molecules bifonctionnelles |
| TWI227241B (en) * | 1998-06-20 | 2005-02-01 | United Biomedical Inc | IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate |
| US6451986B1 (en) | 1998-06-22 | 2002-09-17 | Immunex Corporation | Site specific protein modification |
| US6461849B1 (en) | 1998-10-13 | 2002-10-08 | Novozymes, A/S | Modified polypeptide |
| US6403312B1 (en) | 1998-10-16 | 2002-06-11 | Xencor | Protein design automatic for protein libraries |
| US6686164B1 (en) | 1998-10-30 | 2004-02-03 | Novozymes A/S | Low allergenic protein variants |
| JP4812167B2 (ja) | 1999-02-12 | 2011-11-09 | モレキュラー インサイト ファーマスーティカルズ インコーポレイテッド | 薬物輸送用マトリックス、ならびにその作成方法および使用方法 |
| ATE300952T1 (de) * | 1999-12-09 | 2005-08-15 | Chiron Corp | Verfahren zur verabreichung von wirkstoffen in das zentrale nervensystem oder lymphsystem |
| US6586398B1 (en) | 2000-04-07 | 2003-07-01 | Amgen, Inc. | Chemically modified novel erythropoietin stimulating protein compositions and methods |
| WO2001079469A2 (fr) | 2000-04-14 | 2001-10-25 | University Of South Carolina Research Foundation | Clonage, surexpression et utilisation therapeutique de l'histidine ammoniac lyase bioactive |
| US6967097B2 (en) | 2000-07-24 | 2005-11-22 | Pcbu Services, Inc. | Phenylalainine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same |
| ATE545703T1 (de) * | 2000-07-25 | 2012-03-15 | Immunomedics Inc | Multivalentes zielbindendes protein |
| AU2001294774A1 (en) * | 2000-09-26 | 2002-04-08 | The Regents Of The University Of California | Characterization of phenylalanine ammonia-lyase (pal) gene in wounded lettuce |
| AU2002213843B2 (en) * | 2000-11-10 | 2008-02-07 | F. Hoffmann-La Roche Ltd. | Apolipoprotein analogues |
| EP1476563B1 (fr) | 2002-02-26 | 2008-09-17 | E.I. Du Pont De Nemours And Company | Procede pour la recombinaison d'elements genetiques |
| AU2003246690B2 (en) * | 2002-07-17 | 2010-03-11 | Cytos Biotechnology Ag | Molecular antigen arrays using a virus like particle derived from the AP205 coat protein |
| CA2506026A1 (fr) | 2002-11-14 | 2004-05-27 | The Scripps Research Institute | Forme cristalline de l'amine hydrolase d'acide gras (faah) |
| RU2403262C2 (ru) * | 2003-06-11 | 2010-11-10 | Уайт | Выделенный полипептид ib альфа гликопротеина тромбоцитов человека, слитый белок, молекула днк (варианты), экспрессирующий вектор (варианты), клетка (варианты), способ экспрессии полипептида, способ экспрессии слитого белка, фармацевтическая композиция (варианты), способ ингибирования прикрепления клетки крови к биологической ткани в биологической системе, способ ингибирования прикрепления белка к биологической ткани в биологической системе и способ лечения нарушения |
| FR2868318B1 (fr) * | 2004-04-01 | 2012-11-16 | Commissariat Energie Atomique | Antigene tat stabilise et ses applications pour la vaccination anti-vih |
| US7670595B2 (en) * | 2004-06-28 | 2010-03-02 | Merck Patent Gmbh | Fc-interferon-beta fusion proteins |
| EP1814984A2 (fr) | 2004-09-17 | 2007-08-08 | Biomarin Pharmaceutical Inc. | Variants et variants chimiquement modifies de phenylalanine ammonia-lyase |
| EP1869174B1 (fr) | 2005-03-10 | 2015-02-18 | BASF Enzymes LLC | Lyases, acides nucleiques codant pour celles-ci et methodes de fabrication et d'utilisation |
| US7534595B2 (en) * | 2006-06-12 | 2009-05-19 | Biomarin Pharmaceutical Inc. | Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof |
| WO2008069958A2 (fr) | 2006-12-01 | 2008-06-12 | The Salk Institute For Biological Studies | Ammonia lyases et mutases à substrat modifié |
| US7560263B2 (en) | 2007-08-17 | 2009-07-14 | Biomarin Pharmaceutical Inc. | Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof |
-
2007
- 2007-05-25 US US11/807,227 patent/US7534595B2/en active Active
-
2008
- 2008-05-23 AR ARP080102198A patent/AR066716A1/es active IP Right Grant
- 2008-05-23 MX MX2009012453A patent/MX2009012453A/es active IP Right Grant
- 2008-05-23 KR KR20157007821A patent/KR20150038753A/ko not_active Ceased
- 2008-05-23 EP EP13169362.4A patent/EP2657335A1/fr not_active Withdrawn
- 2008-05-23 SI SI200831540T patent/SI2152868T1/sl unknown
- 2008-05-23 PL PL08754717T patent/PL2152868T3/pl unknown
- 2008-05-23 CA CA2687450A patent/CA2687450C/fr active Active
- 2008-05-23 DK DK08754717.0T patent/DK2152868T3/en active
- 2008-05-23 AU AU2008263190A patent/AU2008263190B2/en active Active
- 2008-05-23 BR BRPI0811267A patent/BRPI0811267B8/pt active IP Right Grant
- 2008-05-23 CL CL2008001497A patent/CL2008001497A1/es unknown
- 2008-05-23 TW TW097119178A patent/TWI418633B/zh active
- 2008-05-23 PT PT87547170T patent/PT2152868E/pt unknown
- 2008-05-23 JP JP2010509405A patent/JP5670183B2/ja active Active
- 2008-05-23 ES ES08754717.0T patent/ES2551315T3/es active Active
- 2008-05-23 MY MYPI20094868 patent/MY151413A/en unknown
- 2008-05-23 HU HUE08754717A patent/HUE025784T2/en unknown
- 2008-05-23 HR HRP20151268TT patent/HRP20151268T1/hr unknown
- 2008-05-23 EP EP08754717.0A patent/EP2152868B1/fr active Active
- 2008-05-23 EA EA200970980A patent/EA018443B1/ru unknown
- 2008-05-23 WO PCT/US2008/006661 patent/WO2008153776A1/fr not_active Ceased
- 2008-05-23 KR KR1020097027018A patent/KR101603796B1/ko active Active
- 2008-05-23 PE PE2008000889A patent/PE20090315A1/es active IP Right Grant
- 2008-05-23 CN CN200880016898.4A patent/CN101842482B/zh active Active
-
2009
- 2009-11-15 IL IL202132A patent/IL202132A/en active IP Right Grant
-
2015
- 2015-11-06 CY CY20151100997T patent/CY1116894T1/el unknown
-
2018
- 2018-01-17 AR ARP180100106A patent/AR110834A2/es unknown
-
2019
- 2019-10-09 NL NL301011C patent/NL301011I2/nl unknown
- 2019-10-10 LT LTPA2019517C patent/LTC2152868I2/lt unknown
- 2019-10-14 LU LU00133C patent/LUC00133I2/fr unknown
- 2019-10-16 NO NO2019037C patent/NO2019037I1/no unknown
- 2019-10-17 CY CY2019039C patent/CY2019039I1/el unknown
- 2019-10-18 HU HUS1900049C patent/HUS1900049I1/hu unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LUC00133I1 (fr) | ||
| CN300730242S (zh) | 订书机(u1) | |
| CN300726100S (zh) | 扇托(2) | |
| CN300916240S (zh) | 移动电源(l50) | |
| CN300907170S (zh) | 床上用品套件(x162) | |
| CN300728768S (zh) | 墙纸(22) | |
| CN300888575S (zh) | 浴镜(古典浴室家具-奥拓桑托系列) | |
| CN300883522S (zh) | 儿童玩具(双圈熊) | |
| CN300728795S (zh) | 包装膜(金华火腿风味) | |
| CN300728899S (zh) | 双人床(b) | |
| CN300730061S (zh) | 鼠标(um-3158) | |
| CN300730139S (zh) | 电路板(开关量计数卡) | |
| CN300799102S (zh) | 绒布(经编人造印花毛皮5) | |
| CN300728918S (zh) | 餐台(7660) | |
| CN300792998S (zh) | 摩托车(永源之星) | |
| CN300790959S (zh) | 幼儿教学卡片(三) | |
| CN300781583S (zh) | 车用喇叭 | |
| CN300728927S (zh) | 桌子(9) | |
| CN300860747S (zh) | 碗(餐具年年有余) | |
| CN300753768S (zh) | 密纬大提花(2) | |
| CN300751968S (zh) | 地毯(2007-41) | |
| CN300960670S (zh) | 出药滑道 | |
| CN300730243S (zh) | 打孔机(u30) | |
| CN300730245S (zh) | 订书机(pod-05) | |
| CN300812472S (zh) | 垃圾筒(1) |